Skip to main content
. 2021 Aug 7;9(8):976. doi: 10.3390/biomedicines9080976

Figure 2.

Figure 2

Combination matrices of hydralazine and enzalutamide (A) or bicalutamide (B) in PCa (prostate cancer) cell lines. The CompuSyn software was used to calculate the drug combination index, with a value lower than 1 indicating synergistic effects, a value of 1 denoting an additive effect, and a value higher than 1 implying antagonistic effects. (X—impossible to calculate).